| 1 |
carfilzomib
(68 times)
|
Neoplasms
(24 times)
|
MM (19 times)
BTZ (14 times)
PI (7 times)
|
2010 The pan-HDAC inhibitor vorinostat potentiates the activity of the proteasome inhibitor carfilzomib in human DLBCL cells in vitro and in vivo.
|
| 2 |
clofazimine
(62 times)
|
Pulmonary Medicine
(12 times)
|
BDQ (9 times)
MDR-TB (9 times)
TB (8 times)
|
1991 [Therapeutic efficacy of kanamycin and clofazimine combined with muramyl dipeptide against Mycobacterium intracellulare infection induced in mice].
|
| 3 |
cefazolin
(39 times)
|
Anti-Bacterial Agents
(9 times)
|
MRSA (9 times)
CTX (7 times)
AMP (4 times)
|
1982 [Antibacterial activity of netilmicin in combination with other antibiotics. Comparison with other aminoglycosides (author's transl)].
|
| 4 |
ceftazidime
(9 times)
|
Microbiology
(2 times)
|
GCE (2 times)
AMI (1 time)
AMK (1 time)
|
1990 Biochemical aspects of the renal tolerance for cefpirome and other cephalosporins.
|
| 5 |
capillary-free zone
(4 times)
|
Ophthalmology
(2 times)
|
CEIFL (1 time)
CMT (1 time)
dERM (1 time)
|
1994 Microvascular pattern of the retina in the Japanese monkey (Macaca fuscata fuscata).
|
| 6 |
Carey-Fineman-Ziter
(4 times)
|
Genetics, Medical
(2 times)
|
MRI (1 time)
|
1999 Carey-Fineman-Ziter (CFZ) syndrome: report on affected sibs.
|
| 7 |
chlorfluazuron
(4 times)
|
Chemistry Techniques, Analytical
(2 times)
|
FZN (2 times)
CSIs (1 time)
GC-MS (1 time)
|
1996 Development of a reference material for residues of chlorfluazuron and fluazuron in beef fat ACSL CRM 3Part I. Preparation, homogeneity and stabilit.
|
| 8 |
Canagliflozin
(3 times)
|
Diabetes Mellitus
(1 time)
|
IS (1 time)
MET (1 time)
MRM (1 time)
|
2014 Canagliflozin-current status in the treatment of type 2 diabetes mellitus with focus on clinical trial data.
|
| 9 |
cefazolin sodium
(2 times)
|
Biochemistry
(1 time)
|
BC (1 time)
BET (1 time)
DRS (1 time)
|
2005 Voltammetric behavior and assay of the antibiotic drug cefazolin sodium in bulk form and pharmaceutical formulation at a mercury electrode.
|
| 10 |
complementary fusing zone
(2 times)
|
Biophysics
(2 times)
|
SVZs (1 time)
|
2015 Generation of 360 three-dimensional display using circular-aligned OLED microdisplays.
|
| 11 |
cefatrizine
(1 time)
|
Pharmacology
(1 time)
|
AUC (1 time)
|
1991 Theoretical model for both saturable rate and extent of absorption: simulations of cefatrizine data.
|
| 12 |
central flattened zone
(1 time)
|
Ophthalmology
(1 time)
|
ASZ (1 time)
CRT (1 time)
TZ (1 time)
|
2007 The relationship between the treatment zone diameter and visual, optical and subjective performance in Corneal Refractive Therapy lens wearers.
|
| 13 |
central foveal zone
(1 time)
|
Genetics, Medical
(1 time)
|
CAI (1 time)
MCS (1 time)
OCT (1 time)
|
2016 Macular cystoid spaces in patients with retinal dystrophy.
|
| 14 |
CFZ-alb NC
(1 time)
|
Pharmacology
(1 time)
|
NC (1 time)
|
2019 Expanding therapeutic utility of carfilzomib for breast cancer therapy by novel albumin-coated nanocrystal formulation.
|
| 15 |
CFZ-HCl
(1 time)
|
Chemistry
(1 time)
|
---
|
2017 Elasticity in Macrophage-Synthesized Biocrystals.
|
| 16 |
chaperone for clofazimine
(1 time)
|
Biomedical Engineering
(1 time)
|
AP (1 time)
DMSO (1 time)
MSNs (1 time)
|
2018 Facile Strategy Enabling Both High Loading and High Release Amounts of the Water-Insoluble Drug Clofazimine Using Mesoporous Silica Nanoparticles.
|
A Search Service for Abbreviation / Long Form